• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人CTLA-4的溶液结构以及CD28中保守的CD80/CD86结合位点的描绘。

Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.

作者信息

Metzler W J, Bajorath J, Fenderson W, Shaw S Y, Constantine K L, Naemura J, Leytze G, Peach R J, Lavoie T B, Mueller L, Linsley P S

出版信息

Nat Struct Biol. 1997 Jul;4(7):527-31. doi: 10.1038/nsb0797-527.

DOI:10.1038/nsb0797-527
PMID:9228944
Abstract

The structure of human CTLA-4 reveals that residues Met 99, Tyr 100 and Tyr 104 of the M99YPPPY104 motif are adjacent to a patch of charged surface residues on the A'GFCC' face of the protein. Mutation of these residues, which are conserved in the CTLA-4/CD28 family, significantly reduces binding to CD80 and/or CD86, implicating this patch as a ligand binding site.

摘要

人类CTLA-4的结构显示,M99YPPPY104基序中的甲硫氨酸99、酪氨酸100和酪氨酸104残基毗邻该蛋白A'GFCC'面上的一片带电荷的表面残基。这些在CTLA-4/CD28家族中保守的残基发生突变,会显著降低与CD80和/或CD86的结合,表明这片区域是一个配体结合位点。

相似文献

1
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.人CTLA-4的溶液结构以及CD28中保守的CD80/CD86结合位点的描绘。
Nat Struct Biol. 1997 Jul;4(7):527-31. doi: 10.1038/nsb0797-527.
2
Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.CD28/CTLA-4的共价二聚化以及CD80/CD86的寡聚化调节T细胞共刺激相互作用。
J Biol Chem. 1996 Oct 25;271(43):26762-71. doi: 10.1074/jbc.271.43.26762.
3
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.人B7-1(CD80)和B7-2(CD86)与CD28和CTLA-4受体结合时亲和力相似,但动力学特性不同。
Immunity. 1994 Dec;1(9):793-801. doi: 10.1016/s1074-7613(94)80021-9.
4
Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28.牛的细胞毒性T淋巴细胞相关抗原4(CTLA-4)、细胞毒性T淋巴细胞相关抗原28(CD28)以及鸡的CD28均可结合CD86:牛CD28中不保守存在“MYPPPY”序列。
Immunogenetics. 1996;43(6):388-91. doi: 10.1007/BF02199808.
5
Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.CD80的两个细胞外免疫球蛋白样结构域都含有与T细胞表面受体CTLA-4和CD28结合至关重要的残基。
J Biol Chem. 1995 Sep 8;270(36):21181-7. doi: 10.1074/jbc.270.36.21181.
6
Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail.细胞毒性T淋巴细胞相关分子4是一种与CD80和CD86具有高亲和力的受体,其胞质尾部含有一个细胞内定位基序。
J Biol Chem. 1995 Oct 20;270(42):25107-14. doi: 10.1074/jbc.270.42.25107.
7
CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.T细胞激活过程中的CD28/CTLA-4受体结构、结合化学计量和聚集
Res Immunol. 1995 Mar-Apr;146(3):130-40. doi: 10.1016/0923-2494(96)80246-x.
8
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.共刺激分子CD80和CD86及其受体CD28、CTLA-4在卵巢癌及其他类型腹膜癌患者恶性腹水中CD3⁺肿瘤浸润淋巴细胞(TIL)上的表达。
Clin Exp Immunol. 2000 Jan;119(1):19-27. doi: 10.1046/j.1365-2249.2000.01105.x.
9
Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.鉴定CD80(B7-1)V结构域中与CD28和CTLA4功能相互作用相关的残基。
J Exp Med. 1995 Sep 1;182(3):667-75. doi: 10.1084/jem.182.3.667.
10
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.B70/B7 - 2与CD86相同,是人类树突状细胞上表达的CD28的主要功能性配体。
J Exp Med. 1994 Nov 1;180(5):1841-7. doi: 10.1084/jem.180.5.1841.

引用本文的文献

1
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy.免疫检查点的翻译后修饰:开启癌症免疫治疗的新潜力。
Exp Hematol Oncol. 2025 Mar 14;14(1):37. doi: 10.1186/s40164-025-00627-6.
2
Extraordinary diversity of the CD28/CTLA4 family across jawed vertebrates.硬骨鱼类中的 CD28/CTLA4 家族具有非凡的多样性。
Front Immunol. 2024 Nov 13;15:1501934. doi: 10.3389/fimmu.2024.1501934. eCollection 2024.
3
Immunomodulatory Precision: A Narrative Review Exploring the Critical Role of Immune Checkpoint Inhibitors in Cancer Treatment.
免疫调节精准度:探索免疫检查点抑制剂在癌症治疗中关键作用的叙述性综述。
Int J Mol Sci. 2024 May 17;25(10):5490. doi: 10.3390/ijms25105490.
4
Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancer.利用人工智能发现抑制癌症中CTLA-4的小分子
BJC Rep. 2024;2. doi: 10.1038/s44276-023-00035-5. Epub 2024 Jan 23.
5
Structural and functional insights into the modulation of T cell costimulation by monkeypox virus protein M2.猴痘病毒蛋白 M2 对 T 细胞共刺激的调节的结构和功能见解
Nat Commun. 2023 Aug 25;14(1):5186. doi: 10.1038/s41467-023-40748-2.
6
Computational design of a cyclic peptide that inhibits the CTLA4 immune checkpoint.一种抑制CTLA4免疫检查点的环肽的计算设计
RSC Med Chem. 2023 Mar 1;14(4):658-670. doi: 10.1039/d2md00409g. eCollection 2023 Apr 26.
7
rs2013278 in the multiple immunological-trait susceptibility locus CD28 regulates the production of non-functional splicing isoforms.rs2013278 位于多个免疫特质易感基因座 CD28 中,调控无功能剪接异构体的产生。
Hum Genomics. 2022 Oct 21;16(1):46. doi: 10.1186/s40246-022-00419-7.
8
Delivery of antigen to porcine dendritic cells by fusing antigen with porcine dendritic cells targeting peptide.通过将抗原与猪树突状细胞靶向肽融合将抗原递送至猪树突状细胞。
Front Immunol. 2022 Sep 8;13:926279. doi: 10.3389/fimmu.2022.926279. eCollection 2022.
9
Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patients.基于纳米抗体的 CTLA4 抑制剂用于犬癌症患者的免疫检查点阻断治疗。
Sci Rep. 2021 Oct 21;11(1):20763. doi: 10.1038/s41598-021-00325-3.
10
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy.用于癌症免疫治疗的调节性T细胞中的CTLA-4
Cancers (Basel). 2021 Mar 22;13(6):1440. doi: 10.3390/cancers13061440.